HR 2746 · 112th Congress 2011–2013, ended

Cancer Drug Coverage Parity Act of 2011

Latest action · Sep 8, 2011 Referred to the Subcommittee on Health, Employment, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedAug 1, 2011
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Cancer Drug Coverage Parity Act of 2011 - Amends the Employee Retirement Income Security Act of 1974 (ERISA), the Public Health Service Act, and the Internal Revenue Code to require a group or individual health plan providing benefits for intravenously administered or injected anticancer medications to provide no less favorable coverage for prescribed, orally administered anticancer medication that is used to kill or slow the growth of cancerous cells and that has been approved by the Food and Drug Administration (FDA).

Applies such requirement to medication that is prescribed based on a finding by the treating physician that the medication is: (1) medically necessary for the purpose of killing or slowing the growth of cancerous cells in accordance with nationally accepted standards of medical practice; (2) clinically appropriate in terms of type, frequency, extent site, and duration; and (3) not primarily for the convenience of the patient, physician, or other health care provider.

Permits such coverage to be subject to the same cost-sharing applicable to intravenously administered or injected anticancer medications under the plan.

Prohibits a health plan from imposing an increase in out-of-pocket costs, or reclassifying benefits, with respect to anticancer medications.

Requires a plan to provide notice to each participant and beneficiary regarding the coverage required under this Act.

Prohibits a health plan from taking specified actions to avoid the requirements of this Act.

Requires the Medicare Payment Advisory Commission to assess how closing the Medicare part D donut hole affects Medicare coverage for orally administered anticancer medications, with a particular focus on cost and accessibility.

Cosponsors 53

Members who signed on, in the order they did. Signatures ran from Sep 23, 2011 to Sep 21, 2012.

SeatCosponsorSigned on
D-MABarney FrankSep 23, 2011
D-CAJoe BacaSep 23, 2011
D-NYSteve IsraelSep 23, 2011
R-NEJeff FortenberryNov 15, 2011
D-NJRush HoltNov 15, 2011
D-NYCarolyn B. MaloneyDec 6, 2011
D-NYCharles B. RangelDec 6, 2011
D-COJared PolisDec 6, 2011
D-TXSilvestre ReyesDec 19, 2011
D-CAGrace F. NapolitanoJan 18, 2012
D-NYGary L. AckermanFeb 1, 2012
D-CAJudy ChuFeb 1, 2012
R-NYPeter T. KingFeb 1, 2012
D-VAJames P. MoranFeb 6, 2012
D-CALois CappsFeb 6, 2012

Committees 3

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Aug 1, 2011
Health Subcommittee
Referred Aug 5, 2011
HouseWays and Means Committee
Referred Aug 1, 2011
Health Subcommittee
Referred Aug 5, 2011
HouseEducation and Workforce Committee
Referred Aug 1, 2011
Health, Employment, Labor, and Pensions Subcommittee
Referred Sep 8, 2011

Actions 4

Everything that happened, newest first.

  1. Sep 8, 2011Referred to the Subcommittee on Health, Employment, Labor, and Pensions.
  2. Aug 5, 2011Referred to the Subcommittee on Health.
  3. Aug 1, 2011Introduced in House
  4. Aug 1, 2011Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H4076Brian Higgins D-NYJun 27, 2012

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: The constitution authority of this legislation lies in the power of congress to regulate commercial activity as described in Article 1, Section 8, Clause 3.

The sponsor’s statement, as printed in the page H5886.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 112-153PUBLIC TRANSPORTATION: PRIORITIES AND CHALLENGES FOR REAUTHORIZATION111 pagesBanking, Housing, and Urban Affairs CommitteeMay 19, 2011

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Employee Retirement Income Security Act of 1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on terms no less favorable than the coverage provided for intravenously administered anticancer medications.
Short Titles as Introduced
Cancer Drug Coverage Parity Act of 2011

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Aug 1, 2011Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.